To address the knowledge gap in research on diagnostic biomarkers, which currently focuses on urine, we conducted the present retrospective study, which aimed to confirm the utility of NGAL and KIM-1 as plasma markers for the early detection of CKD. The gene discussed is LCN2; the disease is chronic kidney disease.